<DOC>
	<DOCNO>NCT02641197</DOCNO>
	<brief_summary>The objective study define repeatability reproducibility quantify flow-mediated dilation ( FMD ) brachial artery ( BA ) use AngioDefender ( AD ) methodology . Repeatability assess repeat AD testing subject 1 hour apart , use AD device operator . Reproducibility assess compare FMD score obtain subject , use different AD device operator .</brief_summary>
	<brief_title>Vascular Reactivity Assessment AngioDefender Device -- A Precision Study</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>1 . Men woman , ≥18 year old 2 . Eastern Cooperative Oncology Group/Zubrod score performance status 0 , 1 , 2 , determine within 7 day prior FMD test Study Day 1 ( Visit 1 ) 3 . Written inform consent understood sign ; understand study procedure ability comply length study 1 . Body mass index ( BMI ) &gt; 50 kg/m2 2 . Midupper arm circumference arm select FMD test &lt; 17 cm &gt; 42 cm 3 . Sinus arrhythmia , atrial fibrillation , atrial flutter , multifocal atrial tachycardia , frequent ( &gt; 1 per 10sec strip ) premature atrial ventricular contraction ( isolate , nonisolated , alternate ) , document 12lead ECG rhythm strip time subject screening . 4 . Clinical sign and/or symptom active viral bacterial infection 5 . Resting muscle tremor inability remain still duration test period 6 . Systolic blood pressure ( SBP ) rest &gt; 170 mmHg diastolic blood pressure ( DBP ) rest ≥110 mmHg . 7 . Diabetic subject Type I II 8 . Previous intolerable adverse reaction ( ) vascular test use upper extremity occlusive pneumatic cuff</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>flow-mediated dilation</keyword>
	<keyword>AngioDefender</keyword>
	<keyword>device precision</keyword>
	<keyword>repeatability</keyword>
	<keyword>reproducibility</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>